Literature DB >> 33504644

N-of-1 Trials in Rare Genetic Neurodevelopmental Disorders: Opportunities for Improvement.

Adam L Hartman1.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 33504644     DOI： 10.1212/WNL.0000000000011603

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  3 in total

Review 1.  Rational Small Molecule Treatment for Genetic Epilepsies.

Authors:  Ethan M Goldberg
Journal:  Neurotherapeutics       Date:  2021-08-24       Impact factor: 6.088

Review 2.  N-of-1 trials to facilitate evidence-based deprescribing: Rationale and case study.

Authors:  Parag Goyal; Monika M Safford; Sarah N Hilmer; Michael A Steinman; Daniel D Matlock; Mathew S Maurer; Mark S Lachs; Ian M Kronish
Journal:  Br J Clin Pharmacol       Date:  2022-07-13       Impact factor: 3.716

3.  Gene-Targeted Therapies in Pediatric Neurology: Challenges and Opportunities in Diagnosis and Delivery.

Authors:  Renée A Shellhaas; Gabrielle deVeber; Joshua L Bonkowsky
Journal:  Pediatr Neurol       Date:  2021-09-25       Impact factor: 4.210
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.